7 August 2020 - This paper describes the implementation of multi-criteria decision analysis into a Canadian public drug reimbursement decision-making process, identifying the aspects of the multi-criteria decision analysis approach, and the context that promoted uptake.

Faced with a fixed budget, a pipeline of expensive but potentially valuable drugs, and potential delays to drug decision making, the Ministry of Health (i.e., decision-makers) and its independent expert advisory committee sought alternative values-based decision processes. 

Multi-criteria decision analysis was considered highly compatible with current processes, but the ability as a stand-alone intervention to address issues of opportunity cost was unclear.

Read International Journal of Technology Assessment in Health Care article